Literature DB >> 21492857

T cell activation predicts carotid artery stiffness among HIV-infected women.

Robert C Kaplan1, Elizabeth Sinclair, Alan L Landay, Nell Lurain, A Richey Sharrett, Stephen J Gange, Xiaonan Xue, Christina M Parrinello, Peter Hunt, Steven G Deeks, Howard N Hodis.   

Abstract

OBJECTIVES: HIV disease is associated with increased arterial stiffness, which may be related to inflammation provoked by HIV-related immune perturbation. We assessed the association of T cell markers of immune activation and immunosenescence with carotid artery stiffness among HIV-infected women.
METHODS: Among 114 HIV-infected and 43 HIV-uninfected women, we measured CD4+ and CD8+ T cell populations expressing activation (CD38+HLA-DR+) and senescence (CD28-CD57+) markers. We then related these measures of immune status with parameters of carotid artery stiffness, including decreased distensibility, and increased Young's elastic modulus, as assessed by B-mode ultrasound.
RESULTS: HIV infection was associated with increased CD4+ T cell activation, CD8+ T cell activation and CD8+ T cell senescence. Among HIV-infected women, adjusted for age, HIV medications, and vascular risk factors, higher CD4+CD38+HLA-DR+ T cell frequency was associated with decreased carotid artery distensibility (β=-2.00, 95% confidence interval [CI]=-3.86, -0.14, P=0.04) and increased Young's modulus (β=1.00, 95% CI=0.03, 1.97, P=0.04). These associations were affected little by further adjustment for CD4+ T cell count and viral load. Among HIV-infected women, higher frequencies of immunosenescent T cells, including CD4+CD28-CD57+ and CD8+CD28-CD57+ T cells, were also associated with decreased arterial distensibility. Among HIV-uninfected women, frequencies of activated or senescent T cells were not significantly associated with measures of carotid stiffness. DISCUSSION: T cell activation and senescence are associated with arterial stiffness, suggesting that pro-inflammatory populations of T cells may produce functional or structural vascular changes in HIV-infected women.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21492857      PMCID: PMC3139014          DOI: 10.1016/j.atherosclerosis.2011.03.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

1.  Association between human immunodeficiency virus infection and stiffness of the common carotid artery.

Authors:  Eric C Seaberg; Lorie Benning; A Richey Sharrett; Jason M Lazar; Howard N Hodis; Wendy J Mack; Mark J Siedner; John P Phair; Lawrence A Kingsley; Robert C Kaplan
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

2.  Surgical experience with carotid stenosis in young HIV-1 positive patients under antiretroviral therapy: an emerging problem?

Authors:  G Regina; G Impedovo; D Angiletta; F Martiradonna; A Lillo; F Perilli; V Marotta; A Marzullo; G Epifani; J R Fiore; P Maggi
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-02       Impact factor: 7.069

3.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.

Authors:  Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.

Authors:  Jennifer E Ho; Steven G Deeks; Frederick M Hecht; Yu Xie; Amanda Schnell; Jeffrey N Martin; Peter Ganz; Priscilla Y Hsue
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

5.  Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.

Authors:  Frank J Palella; Stephen J Gange; Lorie Benning; Lisa Jacobson; Robert C Kaplan; Alan L Landay; Russell P Tracy; Richard Elion
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

6.  Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke.

Authors:  Antonino Tuttolomondo; Domenico Di Raimondo; Rosaria Pecoraro; Antonia Serio; Gisella D'Aguanno; Antonio Pinto; Giuseppe Licata
Journal:  Atherosclerosis       Date:  2010-08-26       Impact factor: 5.162

7.  Atherosclerotic risk factors and carotid stiffness in elderly asymptomatic HD patients.

Authors:  Paraskevi Tseke; Eirini Grapsa; Kimon Stamatelopoulos; Elisabeth Samouilidou; Athanasios Protogerou; Christos Papamichael; Antonios Laggouranis
Journal:  Int Urol Nephrol       Date:  2006-11-07       Impact factor: 2.370

Review 8.  Adaptive immunity and atherosclerosis.

Authors:  John Andersson; Peter Libby; Göran K Hansson
Journal:  Clin Immunol       Date:  2009-07-26       Impact factor: 3.969

9.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Authors:  Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

10.  Aortic stiffness in untreated adult patients with human immunodeficiency virus infection.

Authors:  Giuseppe Schillaci; Giuseppe V L De Socio; Giacomo Pucci; Massimo R Mannarino; Johny Helou; Matteo Pirro; Elmo Mannarino
Journal:  Hypertension       Date:  2008-06-16       Impact factor: 10.190

View more
  65 in total

1.  Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.

Authors:  Jason D Barbour; Emilie C Jalbert; Dominic C Chow; Louie Mar A Gangcuangco; Philip J Norris; Sheila M Keating; John Heitman; Lorna Nagamine; Todd Seto; Lishomwa C Ndhlovu; Beau K Nakamoto; Howard N Hodis; Nisha I Parikh; Cecilia M Shikuma
Journal:  Atherosclerosis       Date:  2013-10-31       Impact factor: 5.162

2.  Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis.

Authors:  Nwora Lance Okeke; Tammy Chin; Meredith Clement; Shein-Chung Chow; Charles B Hicks
Journal:  AIDS Care       Date:  2015-10-19

3.  T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.

Authors:  Roksana Karim; Wendy J Mack; Naoko Kono; Phyllis C Tien; Kathryn Anastos; Jason Lazar; Mary Young; Seema Desai; Elizabeth T Golub; Robert C Kaplan; Howard N Hodis; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

Review 4.  The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.

Authors:  Cornelia M Weyand; Gerald J Berry; Jörg J Goronzy
Journal:  J Leukoc Biol       Date:  2017-12-29       Impact factor: 4.962

Review 5.  Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.

Authors:  Anna C Hearps; Genevieve E Martin; Reena Rajasuriar; Suzanne M Crowe
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

6.  Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.

Authors:  Kristine M Erlandson; Maryann OʼRiordan; Danielle Labbato; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

7.  Association of T Cell and Macrophage Activation with Arterial Vascular Health in HIV.

Authors:  Heather N Grome; Louise Barnett; Cindy C Hagar; David G Harrison; Spyros A Kalams; John R Koethe
Journal:  AIDS Res Hum Retroviruses       Date:  2016-09-14       Impact factor: 2.205

8.  CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy.

Authors:  Jessica L Castilho; Bryan E Shepherd; John Koethe; Megan Turner; Sally Bebawy; James Logan; William B Rogers; Stephen Raffanti; Timothy R Sterling
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

Review 9.  Cancer prevention in HIV-infected populations.

Authors:  Priscila H Goncalves; Jairo M Montezuma-Rusca; Robert Yarchoan; Thomas S Uldrick
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

10.  Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.

Authors:  C T Longenecker; N T Funderburg; Y Jiang; S Debanne; N Storer; D E Labbato; M M Lederman; G A McComsey
Journal:  HIV Med       Date:  2013-01-18       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.